Prosecution Insights
Last updated: October 25, 2026
Application No. 18/236,150

A Blood Collection Device with Improved Blood Draw Time

Non-Final OA §103
Filed
Aug 21, 2023
Priority
Aug 22, 2022 — provisional 63/399,887
Examiner
LOPEZ, SEVERO ANTON P
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Becton, Dickinson and Company
OA Round
3 (Non-Final)
35%
Grant Probability
At Risk
3-4
OA Rounds
6m
Est. Remaining
75%
With Interview

Examiner Intelligence

Grants only 35% of cases
35%
Career Allowance Rate
59 granted / 169 resolved
-35.1% vs TC avg
Strong +40% interview lift
Without
With
+40.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
58 currently pending
Career history
260
Total Applications
across all art units

Statute-Specific Performance

§101
15.0%
-25.0% vs TC avg
§103
43.9%
+3.9% vs TC avg
§102
18.5%
-21.5% vs TC avg
§112
18.6%
-21.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 169 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 1 September 2026 has been entered. The Examiner acknowledges the amendments to claims 1, 6, and 16, as well as the addition of new claim 23. Claims 1, 3, 5-8, 16, and 19-23 are pending. Claim Objections Claim(s) 1 is/are objected to because of the following informalities: The limitations of lines 16-23 of claim 1 should be tabbed to the left once, as the limitations as currently formatted are tabbed such that they appear to be limitations that specifically further comprise the distal portion of the probe; however, the limitations are directed towards more than just the distal portion of the probe [the limitations further limit the entire probe, as opposed to just the distal portion of the probe/blood collection device; see formatting of claim 16, wherein similar limitations are not tabbed over such that they are further limitations of the distal portion of the probe and are instead formatted as further limitations of the blood collection device]. Appropriate correction is required. Claim Interpretation Examiner Notes: currently, NO limitation invokes interpretation under § 112(f). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1, 3, 5-6, 8, 16, and 19-23 is/are rejected under 35 U.S.C. 103 as being unpatentable over Burkholz (US-20200316346-A1, previously presented) in view of Devgon (US-20140364766-A1 , previously presented). Regarding claim 1, Burkholz teaches A blood collection device comprising: a distal end portion [distal end 52 (Burkholz Fig. 1D); a housing 50, which may include a distal end 52, a proximal end 54 (Burkholz ¶0082)]; a proximal end portion [proximal end 54 (Burkholz ¶0082, Fig. 1D)]; an actuator [guidewire hub 62 (Burkholz Fig. 1D)]; and a probe operably coupled to the actuator [guidewire 48 (Burkholz Figs. 1A, C-E, G-H); the guidewire hub 62 may be configured to move along the slot 56 to advance the guidewire 48 in a distal direction and distal to the distal end 52 of the housing 50 (Burkholz ¶0083)], wherein the actuator is configured to selectively advance the probe through a catheter of a vascular access device when the blood collection device is coupled to the vascular access device [the guidewire 48 may be advanced beyond the distal tip 70 of the catheter 24, which may move or push away anything within the vasculature of the patient that might otherwise occlude the catheter 24 during a blood draw (Burkholz ¶0086, Figs. 1D-E)], wherein the probe comprises a distal portion and a proximal portion, with the proximal portion of the probe comprising a wire section [the fluid permeable structure 64 may include an elongated core 66 (Burkholz ¶0085, Fig. 1H)] and the distal portion of the probe comprising: a tubular section joined with the wire section and extending distally therefrom, the tubular section including a distal end and a proximal end [the guidewire 48 may include a tube 118 in addition to or as an alternative to the coil 68. In some embodiments, the tube 118 may include the fluid permeable structure 64. For example, in some embodiments, the tube 118 may be porous (Burkholz ¶0115), wherein as depicted in at least Burkholz Fig. 1G, the fluid permeable structure is positioned at a distal end of guidewire 48, and wherein a “tube” is considered to be defined as being elongated, such that the tube 118 is considered to comprise a distal end and a proximal end (see also Burkholz Figs. 7E-H, which depict the tube 118 as having a length to define a distal and proximal end], and a distal coil positioned at the distal end of the tubular section and extending distally therefrom [the distal end 60 of the guidewire 48 may include a fluid permeable structure 64. In some embodiments, the fluid permeable structure 64 may include an elongated core 66 and a coil 68 extending around the elongated core 66 (Burkholz ¶0085, Fig. 1H), wherein as the tube 118 may comprise the fluid permeable structure (coil 68), and the coil 68 is positioned at a distal end of the guidewire 48, the coil 68 is considered to be positioned at a distal end of the tubular section and extend distally therefrom], wherein only the distal portion of the probe is configured to extend at least partially beyond a distal tip of the catheter of the vascular access device when the probe is in a fully advanced position [wherein as depicted in Burkholz Fig. 1E, the proximal portion 58 does not extend beyond a distal tip of the catheter], and wherein, with the probe in the fully advanced position, the proximal end of the tubular section extends only to the distal tip of the catheter, such that blood flowing from the tubular section exits the tubular section just proximal to the distal tip [See Examiner’s interpretations of the tube 118 and the coil 68, wherein the Examiner further notes that as depicted in at least Burkholz Figs. 1G-H, 3B, 7C-H, the proximal end of the fluid permeable structure 64 (interpreted to refer to the combination of the tube 118 and coil 68) extends only to the distal tip of the catheter 24, such that blood flowing from the fluid permeable structure exits the fluid permeable structure just proximal to the distal tip of catheter 24, wherein as the coil 68 is considered to be positioned at a distal end of the tube 118, the proximal end of the fluid permeable structure is considered to be defined by the tube 118, such that the functionality of the proximal end of the fluid permeable structure as discussed above is considered to be applicable to the tube 118]. However, Burkholz fails to explicitly disclose wherein the distal portion and the proximal portion of the probe are formed of different materials. Devgon discloses a blood collection device comprising a probe advanced into a patient’s vasculature [the fluid transfer device 15000 includes an introducer 15100, a catheter 15200, an actuator 15570, and an adapter 15450 (Devgon ¶0155, Fig. 47); the bodily fluid (e.g., blood) is drawn through the lumen 15209 of the cannula 15200 and the lumen 15253 of the secondary cannula 15250 and into the fluid container. In this manner, a phlebotomist can collect (e.g., draw) a given amount of blood through an existing peripheral intravenous line without the need for additional needle sticks (Devgon ¶0192)], wherein Devgon discloses wherein the probe comprises a distal portion and a proximal portion, wherein the distal portion and the proximal portion of the probe are formed of different materials [the first portion 15205 of the catheter 15200 can have a Shore durometer that is greater than a Shore durometer of the second portion 15210. For example, in some embodiments, the first portion 15205 can be formed from a first material or first blend of materials and the second portion can be formed from a second material or second blend of materials having a durometer less than a durometer of the first material or first blend of materials… As such, the first portion 15205 can have a stiffness and/or durometer that is sufficient to inhibit a kinking, a pinching, a breaking, and/or an undesirable plastic deformation of the first portion 15205 while being advanced, for example, through the introducer 15100, as described in further detail herein. The second portion 15210 can have a stiffness and/or durometer that is less than the stiffness and/or durometer of the first portion 15210 and as such, can be configured to bend, flex, elastically deform, and/or otherwise reconfigure, which, in some instances, can reduce a likelihood of the second portion 15210 puncturing a vascular tissue when disposed therein and/or allow the second portion 15210 to be advanced through a kink, bend, turn, valve, and/or obstruction in, for example, a lumen defined by a PIV, as described in further detail herein (Devgon ¶0178, Fig. 56)]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the device of Burkholz to employ wherein the distal portion and the proximal portion are formed of different materials, so as to impart mechanical properties to the proximal portion of the probe to inhibit kinking, pinching, breaking, or undesirable plastic deformation as the probe is advanced and impart mechanical properties to the distal portion of the probe to reduce a likelihood of puncturing a vascular tissue as the probe is advanced. Regarding claim 3, Burkholz in view of Devgon teaches The blood collection device of claim 1, wherein the proximal portion of the probe further comprises at least one coil section [the coil 68 may extend into the catheter 24. In some embodiments, the coil 68 may extend through all or a portion of the catheter 24 (Burkholz ¶0098), wherein the portion of the probe (guidewire 48) inside the catheter when extended is considered to be part of the proximal portion; wherein as the distal end 60 of the guidewire 48 comprises the fluid permeable structure 64 (see Burkholz ¶0085, defined as coil 68), and as noted in the § 103 rejection of claim 1 above the guidewire 48 may include a tube 118 in addition to the coil 68 and the tube 118 may comprise the fluid permeable structure 64 (see Burkholz ¶0115), the arrangement of the distal coil relative to the tubular section as recited in claim 1 is still considered applicable]. Regarding claim 5, Burkholz in view of Devgon teaches The blood collection device of claim 1, wherein a distal end of the distal coil is capped [the distal end of the coil 68 may be directly coupled to the rounded distal tip 72 (Burkholz ¶0091)]. Regarding claim 6, Burkholz in view of Devgon teaches The blood collection device of claim 1, wherein the tubular section comprises at least one perforation formed in a sidewall thereof [As illustrated in FIG. 7E, in some embodiments, the tube 118 may include multiple holes 120, which may be arranged in various patterns and numbers and may include various sizes. In some embodiments, the holes 120 may be disposed on a distal end 122 of the tube 118 (Burkholz ¶0115, Figs. 7E-F); As illustrated in FIG. 7G, in some embodiments, the tube 118 may include multiple slits 124, which may be arranged in various patterns and numbers and may include various sizes. In some embodiments, the slits 124 may be disposed on the distal end 122 of the tube 118 (Burkholz ¶0117, Figs. 7G-H)]. Regarding claim 8, Burkholz in view of Devgon teaches The blood collection device of claim 1. The Examiner notes that while the limitation “wherein the tubular section and the wire section are co-extruded” is considered to refer to a product-by-process limitation [being “co-extruded” is considered to refer to the process by which the tubular section and the wire section are coupled together (MPEP § 2113)], such that the tubular section and the wire section as presently coupled in Burkholz in view of Devgon may be considered to read on the claimed product itself [as any coupled tubular section and wire section are considered to be similarly coupled as a tubular section and a wire section coupled via co-extrusion], even though Burkholz in view of Devgon [as presently modified] fails to explicitly disclose the particular method of forming the tubular section and wire section; for the sake of compact prosecution, the Examiner notes that Devgon discloses the use of co-extrusion to couple separate elements of a probe together [the first portion 15205 can be formed from a first material or first blend of materials and the second portion can be formed from a second material or second blend of materials having a durometer less than a durometer of the first material or first blend of materials. In some embodiments, the first portion 15205 and the second portion 15210 can be, for example, co-extruded (Devgon ¶0178)]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the device of Burkholz in view of Devgon to employ wherein the tubular section and the wire section are co-extruded, as this modification would amount to merely applying a known technique to a known device (method, or product) ready for improvement to yield predictable results [MPEP § 2143(I)(D)]. Regarding claim 16, Burkholz teaches A method of blood sample collection from a patient, the method comprising: providing a vascular access device comprising a catheter adapter and a catheter [the catheter assembly 14 may include a catheter adapter 16… a catheter 24 may be secured to the catheter adapter 16 and may extend distally from the catheter adapter 16 (Burkholz ¶0076, Figs. 1A, D)]; inserting the catheter of the vascular access device into a vein of the patient [the instrument may allow blood to enter the catheter from a longer portion of a vein (Burkholz ¶0009, Fig. 1H)]; providing a blood collection device, the blood collection device comprising: a distal end portion [distal end 52 (Burkholz Fig. 1D); a housing 50, which may include a distal end 52, a proximal end 54 (Burkholz ¶0082)]; a proximal end portion [proximal end 54 (Burkholz ¶0082, Fig. 1D)]; an actuator [guidewire hub 62 (Burkholz Fig. 1D)]; and a probe operably coupled to the actuator [guidewire 48 (Burkholz Figs. 1A, C-E, G-H); the guidewire hub 62 may be configured to move along the slot 56 to advance the guidewire 48 in a distal direction and distal to the distal end 52 of the housing 50 (Burkholz ¶0083)], wherein the probe comprises a distal portion and a proximal portion [the guidewire 48, which may include a proximal end 58 and a distal end 60 (Burkholz ¶0082)], with the proximal portion of the probe comprising a wire section [the fluid permeable structure 64 may include an elongated core 66 (Burkholz ¶0085, Fig. 1H)] and the distal portion of the probe comprising: a tubular section joined with the wire section and extending distally therefrom, the tubular section including a distal end and a proximal end [the guidewire 48 may include a tube 118 in addition to or as an alternative to the coil 68. In some embodiments, the tube 118 may include the fluid permeable structure 64. For example, in some embodiments, the tube 118 may be porous (Burkholz ¶0115), wherein as depicted in at least Burkholz Fig. 1G, the fluid permeable structure is positioned at a distal end of guidewire 48, and wherein a “tube” is considered to be defined as being elongated, such that the tube 118 is considered to comprise a distal end and a proximal end (see also Burkholz Figs. 7E-H, which depict the tube 118 as having a length to define a distal and proximal end], and a distal coil positioned at a distal end of the tubular section and extending distally therefrom [the distal end 60 of the guidewire 48 may include a fluid permeable structure 64. In some embodiments, the fluid permeable structure 64 may include an elongated core 66 and a coil 68 extending around the elongated core 66 (Burkholz ¶0085, Fig. 1H), wherein as the tube 118 may comprise the fluid permeable structure (coil 68), and the coil 68 is positioned at a distal end of the guidewire 48, the coil 68 is considered to be positioned at a distal end of the tubular section and extend distally therefrom], and coupling the blood collection device to the vascular access device [the catheter assembly 14 may include a needleless connector 39, and the delivery device 12 may be coupled to the first port 36 of the connector 34 via the needleless connector 39, which may be disposed between the delivery device 12 and the connector 34 (Burkholz ¶0080, Figs. 1D-E)]; advancing the probe of the blood collection device through the vascular access device and to a fully advanced position such that only the distal portion of the probe extends beyond a distal tip of the catheter [the guidewire 48 may be advanced beyond the distal tip 70 of the catheter 24, which may move or push away anything within the vasculature of the patient that might otherwise occlude the catheter 24 during a blood draw (Burkholz ¶0086, Figs. 1D-E)]; and drawing blood through the distal portion of the probe and into the catheter [the delivery device 12 may include a gap between an outer diameter of the guidewire 48 and the catheter 24, which may allow blood to flow proximally through the gap from the vasculature. In some embodiments, the delivery device 12 may include a gap between the outer diameter of the guidewire 48 and the distal tip 70 of the catheter 24, which may allow blood to flow proximally through the gap from the vasculature (Burkholz ¶0087)], wherein, with the probe in the fully advanced position, the proximal end of the tubular section extends only to the distal tip of the catheter, such that blood flowing from the tubular section exits the tubular section just proximal to the distal tip [See Examiner’s interpretations of the tube 118 and the coil 68, wherein the Examiner further notes that as depicted in at least Burkholz Figs. 1G-H, 3B, 7C-H, the proximal end of the fluid permeable structure 64 (interpreted to refer to the combination of the tube 118 and coil 68) extends only to the distal tip of the catheter 24, such that blood flowing from the fluid permeable structure exits the fluid permeable structure just proximal to the distal tip of catheter 24, wherein as the coil 68 is considered to be positioned at a distal end of the tube 118, the proximal end of the fluid permeable structure is considered to be defined by the tube 118, such that the functionality of the proximal end of the fluid permeable structure as discussed above is considered to be applicable to the tube 118]. However, Burkholz fails to explicitly disclose wherein the distal portion and the proximal portion of the probe are formed of different materials. Devgon discloses a blood collection device comprising a probe advanced into a patient’s vasculature [the fluid transfer device 15000 includes an introducer 15100, a catheter 15200, an actuator 15570, and an adapter 15450 (Devgon ¶0155, Fig. 47); the bodily fluid (e.g., blood) is drawn through the lumen 15209 of the cannula 15200 and the lumen 15253 of the secondary cannula 15250 and into the fluid container. In this manner, a phlebotomist can collect (e.g., draw) a given amount of blood through an existing peripheral intravenous line without the need for additional needle sticks (Devgon ¶0192)], wherein Devgon discloses wherein the probe comprises a distal portion and a proximal portion, wherein the distal portion and the proximal portion of the probe are formed of different materials [the first portion 15205 of the catheter 15200 can have a Shore durometer that is greater than a Shore durometer of the second portion 15210. For example, in some embodiments, the first portion 15205 can be formed from a first material or first blend of materials and the second portion can be formed from a second material or second blend of materials having a durometer less than a durometer of the first material or first blend of materials… As such, the first portion 15205 can have a stiffness and/or durometer that is sufficient to inhibit a kinking, a pinching, a breaking, and/or an undesirable plastic deformation of the first portion 15205 while being advanced, for example, through the introducer 15100, as described in further detail herein. The second portion 15210 can have a stiffness and/or durometer that is less than the stiffness and/or durometer of the first portion 15210 and as such, can be configured to bend, flex, elastically deform, and/or otherwise reconfigure, which, in some instances, can reduce a likelihood of the second portion 15210 puncturing a vascular tissue when disposed therein and/or allow the second portion 15210 to be advanced through a kink, bend, turn, valve, and/or obstruction in, for example, a lumen defined by a PIV, as described in further detail herein (Devgon ¶0178, Fig. 56)]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the method of Burkholz to employ wherein the distal portion and the proximal portion are formed of different materials, so as to impart mechanical properties to the proximal portion of the probe to inhibit kinking, pinching, breaking, or undesirable plastic deformation as the probe is advanced and impart mechanical properties to the distal portion of the probe to reduce a likelihood of puncturing a vascular tissue as the probe is advanced. Regarding claim 19, Burkholz in view of Devgon teaches The method of claim 16, further comprising drawing blood into a blood collection container [the delivery device 108 may include tubing 110, which may include a proximal end 112 and a distal end 114. In some embodiments, the proximal end 112 of the tubing 110 may be coupled to a connector 116, which may include a male or female luer connector with a luer-slip or luer-lock feature. In some embodiments, the connector 116 may be coupled to any suitable blood collection device (Burkholz ¶0111, Fig. 7B)]. Regarding claim 20, Burkholz in view of Devgon teaches The method of claim 19, wherein the blood collection container is fluidly coupled to the blood collection device [Burkholz ¶0111, Figs. 7A-B]. Regarding claim 21, Burkholz in view of Devgon teaches The method of claim 19, wherein the blood collection container is fluidly coupled to the catheter adapter [Burkholz ¶0111, Figs. 7A-B]. Regarding claim 22, Burkholz in view of Devgon teaches The method of claim 16, further comprising advancing the probe through a first port in the catheter adapter and drawing a blood sample through a second port in the catheter adapter [Referring now to FIG. 4A, in some embodiments, the delivery device 12 may be coupled to a proximal port of a T-connector 91, which may include a needleless connector. In some embodiments, a distal port of the T-connector 91 may be coupled to the proximal end 20 of the catheter adapter 16. In these and other embodiments, the catheter adapter 16 may not include the side port 26 and/or an integrated extension tube. In some embodiments, the extension tube 28 may be coupled to a side port of the T-connector, which may be angled with respect to the proximal port and the distal port (Burkholz ¶0101, Fig. 4A), wherein the T-connector being coupled to the catheter adapter 16 is considered to allow the T-connector to read on comprising part of the catheter adapter]. Regarding claim 23, Burkholz in view of Devgon teaches The blood collection device of claim 1, wherein the tubular section terminates at its distal end, and wherein the distal coil extends distally out past the distal end of the tubular section, so as to protrude distally out past the tubular section [wherein as the fluid permeable structure is considered to be defined by the combination of tube 118 and coil 68, wherein the coil 68 is defined as being at the distal end of the probe, such that the tube is considered to be positioned proximal to the coil 68 (see Examiner’s analysis of claim 1 above; Burkholz ¶¶0085, 0115), the tube 118 is considered to terminate at the distal end of the tube and the coil 68 is considered to extend and protrude distally out past the distal end of the tube 118]. Claim(s) 7 is/are rejected under 35 U.S.C. 103 as being unpatentable over Burkholz in view of Devgon, as applied to claim 1 above, in further view of Hayzelden (US-20210322730-A1, previously presented). Regarding claim 7, Burkholz in view of Devgon teaches The blood collection device of claim 1. However, Burkholz in view of Devgon fails to explicitly disclose wherein the wire section is coupled to a proximal end portion of the tubular section via an adhesive. Hayzelden discloses guidewires for intravascular use [the materials and methods of construction and the dimensions of conventional intracorporeal devices such as intravascular guidewires may be employed with a device embodying features of the present invention (Hayzelden ¶0038)], wherein Hayzelden discloses a guidewire comprising distal tubular section and a proximal wire section, wherein the wire section is coupled to a proximal end portion of the tubular section via an adhesive [The tubular member 24 is attached to the distal end 16 of the proximal core wire 12 and to the proximal end 20 of the distal core wire 18 by any suitable means such as by welding, brazing, bonding, and adhesive bonding (Hayzelden ¶0027, Figs. 1-2A)]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the device of Burkholz in view of Devgon to employ wherein the wire section is coupled to a proximal end portion of the tubular section via an adhesive, as this modification would amount to merely applying a known technique to a known device (method, or product) ready for improvement to yield predictable results [MPEP § 2143(I)(D)]. Response to Arguments Applicant’s arguments, see Applicant’s Remarks p. 6, filed 1 September 2026, with respect to the previously presented claim objections have been fully considered and are persuasive. The objection to claim 6 has been withdrawn. Applicant's arguments, see Applicant’s Remarks p. 6-8, with respect to the previously presented rejections of claims 1, 16, and those dependent therefrom under § 103 have been fully considered but they are not persuasive. The Applicant asserts that there is no teaching in Burkholz of tube 118 that, with guidewire 48 in a fully advanced position that the proximal end of the tube 118 extends only to the distal tip 70 of the catheter 24, such that blood flowing from the tube 118 exits the tube 118 just proximal to the distal tip 70, as called for in amended claims 1 and 16. The Applicant further notes that as depicted in Burkholz Figs. 7E and 7F, the proximal end 118 of the tube 118 is positioned well past/proximal to the distal tip 70 of catheter 24. As such, the Applicant asserts that Burkholz (alone or in combination with Devgon) fail(s) to provide any teaching of that which is called for in claims 1 and 16 regarding wherein with the probe in the fully advanced position, the proximal end of the tubular section extends only to the distal tip of the catheter, such that blood flowing from the tubular section exits the tubular section just proximal to the distal tip. However, the Examiner disagrees with the Applicant’s argument, as the Examiner notes that based on the interpretation of Burkholz ¶¶0085, 0115 and Figs. 1H and 7E-H, in which the fluid permeable structure is defined by the tube 118 and the coil 68 extending distally from the tube 118, the proximal end of the fluid permeable structure [considered to be defined by the tube 118] is depicted in at least Burkholz Figs. 1G-H, 3B, and 7C-H as extending only to the distal tip 70 of catheter 24, wherein the “distal” tip 70 of catheter 24 is not considered to be particularly limited to define only a specific amount or length of the catheter 24 [the term “distal” refers to a portion of a catheter system or component thereof that is farther from a user, and the term “proximal” refers to a portion of a catheter system or component thereof that is closer to the user (Burkholz ¶0074)]. The Examiner notes that “proximal” and “distal” are considered to be relative and non-limiting in terms of how much or how long of an element may define a “proximal” or “distal” tip/end, such that the Applicant’s interpretation of Burkholz is considered to be narrower than the argued claim language. As such, Burkholz is considered to teach, disclose, or suggest the argued limitation, based on the Examiner’s analysis above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SEVERO ANTONIO P LOPEZ whose telephone number is (571)272-7378. The examiner can normally be reached M-F 9-6 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Charles Marmor II can be reached at (571) 272-4730. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SEVERO ANTONIO P LOPEZ/Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Aug 21, 2023
Application Filed
Oct 15, 2025
Non-Final Rejection mailed — §103
Dec 22, 2025
Response Filed
Apr 01, 2026
Final Rejection mailed — §103
Sep 01, 2026
Request for Continued Examination
Sep 03, 2026
Response after Non-Final Action
Oct 16, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728198
MEDICAL DEVICE AND METHODS FOR ASSEMBLING AND DISASSEMBLING THE SAME
7y 2m to grant Granted Sep 08, 2026
Patent 12728238
GUIDE WIRE
3y 3m to grant Granted Sep 08, 2026
Patent 12667345
CORE NEEDLE BIOPSY DEVICE FOR COLLECTING MULTIPLE SAMPLES IN A SINGLE INSERTION
4y 2m to grant Granted Jun 30, 2026
Patent 12661041
Cap With Venting Plug for Biological Fluid Collection Device
5y 8m to grant Granted Jun 23, 2026
Patent 12575781
PORTABLE AND WEARABLE ELECTROMYOGRAPHIC BIOFEEDBACK FOR SPINAL CORD INJURY TO ENHANCE NEUROPLASTICITY
6y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
35%
Grant Probability
75%
With Interview (+40.2%)
3y 8m (~6m remaining)
Median Time to Grant
High
PTA Risk
Based on 169 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month